ISIN | CH1109038336 |
---|---|
Valor Number | 110903833 |
Bloomberg Global ID | |
Fund Name | ETHOS - Ethos Equities CH indexed, Corporate Governance Z |
Fund Provider |
Ethos
Genève, Switzerland Phone: +41 22 716 15 55 E-Mail: info@ethosfund.ch Web: www.ethosfund.ch |
Fund Provider | Ethos |
Representative in Switzerland | |
Distributor(s) |
Credit Suisse AG Zürich Phone: +41 44 333 11 11 UBS AG Zürich Phone: +41 44 234 11 11 Vontobel Fonds Services AG Zürich Phone: +41 58 283 74 77 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | The fund charges a transaction fee (contribution towards covering expenses incurred in the sale of assets) |
Investment Strategy *** | The sub-fund's objective is to achieve long-term capital gains by outperforming its benchmark index, the Bloomberg Barclays Global Aggregate Ex CHF Total Return Index Hedged CHF, over a time horizon corresponding to one full economic cycle. The sub-fund is actively managed by combining market research with issuer analysis, as well as taking into consideration environmental, social, and governance (ESG) criteria, with the aim of building a portfolio of securities corresponding to its objective while offering the best risk-adjusted returns. The sub-fund invests mainly in bonds issued in Swiss francs or in any other foreign currency, by private or public issuers from all over the world outside Switzerland, having a minimum Investment Grade rating. |
Peculiarities |
Current Price * | 322.82 CHF | 31.03.2025 |
---|---|---|
Previous Price * | 328.60 CHF | 28.03.2025 |
52 Week High * | 333.84 CHF | 03.03.2025 |
52 Week Low * | 288.10 CHF | 16.04.2024 |
NAV * | 322.82 CHF | 31.03.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 185,760,840 | |
Unit/Share Assets *** | 22,205,916 | |
Trading Information SIX |
YTD Performance | +7.44% |
31.12.2024 - 31.03.2025
31.12.2024 31.03.2025 |
---|---|---|
1 month | -2.15% |
28.02.2025 - 31.03.2025
28.02.2025 31.03.2025 |
3 months | +7.44% |
31.12.2024 - 31.03.2025
31.12.2024 31.03.2025 |
6 months | +2.72% |
30.09.2024 - 31.03.2025
30.09.2024 31.03.2025 |
1 year | +7.83% |
31.03.2024 - 31.03.2025
31.03.2024 31.03.2025 |
2 years | +16.04% |
31.03.2023 - 31.03.2025
31.03.2023 31.03.2025 |
3 years | +9.09% |
31.03.2022 - 31.03.2025
31.03.2022 31.03.2025 |
5 years | +6.08% |
31.08.2021 - 31.03.2025
31.08.2021 31.03.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Nestle SA | 12.81% | |
---|---|---|
Novartis AG Registered Shares | 8.88% | |
Roche Holding AG | 8.79% | |
UBS Group AG | 7.27% | |
Zurich Insurance Group AG | 6.75% | |
ABB Ltd | 6.70% | |
Compagnie Financiere Richemont SA Class A | 3.63% | |
Lonza Group Ltd | 3.31% | |
Swiss Re AG | 3.30% | |
Sika AG | 2.96% | |
Last data update | 31.12.2024 |
TER | 0.06% |
---|---|
TER date | 30.06.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.25% |
Ongoing Charges *** | |
SRRI ***
|
|
SRRI date *** | 28.02.2025 |